ATC
ALXN

Adirondack Trust Company’s Alexion Pharmaceuticals ALXN Stock Holding History

Adirondack Trust Company’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-85
Closed -$10K – 360
2016
Q4 		$10K Buy
85
+10
+13% +$1.22K 0.01% 246
2016
Q3 		$9K Hold
75
– – 0.01% 252
2016
Q2 		$9K Hold
75
– – 0.01% 286
2016
Q1 		$10K Hold
75
– – 0.01% 259
2015
Q4 		$11K Sell
75
-20
-21% -$3.49K 0.01% 246
2015
Q3 		$15K Hold
95
– – 0.01% 215
2015
Q2 		$17K Buy
95
+25
+36% +$4.31K 0.01% 220
2015
Q1 		$12K Buy
70
+35
+100% +$6.33K 0.01% 242
2014
Q4 		$6K Buy
+35
New +$6.49K ﹤0.01% 288

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Adirondack Trust Company's ALXN Position: Q1 2017 in Review

Adirondack Trust Company sold out of Alexion Pharmaceuticals (ALXN) in Q1 2017, closing a stake of 85 shares — an estimated $10K sold.

Adirondack Trust Company first reported a position in ALXN in Q4 2014 and held it in 9 quarters. The position peaked at $17K in Q2 2015. 561 funds tracked by Wall St. Rank hold ALXN as of Q1 2017.

  • Adirondack Trust Company reported no remaining Alexion Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Adirondack Trust Company sold 85 Alexion Pharmaceuticals shares in Q1 2017, an estimated $10K.
  • Adirondack Trust Company first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 9 quarters.
  • Adirondack Trust Company's Alexion Pharmaceuticals position peaked at $17K in Q2 2015.
  • 561 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2017.

Based on Adirondack Trust Company's 13F filing for Q1 2017, filed 12 Apr 2017.